These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9201781)

  • 1. Non-existence of a positive correlation between urinary levels of alpha 1-microglobulin and ulinastatin in patients with Parkinson's disease.
    Inagaki T; Shikimi T; Matsubara K; Kobayashi S; Ishino H; Okunishi H; Takaori S
    Psychiatry Clin Neurosci; 1996 Aug; 50(4):231-3. PubMed ID: 9201781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the ratio of urinary alpha 1-microglobulin to ulinastatin levels in patients with Alzheimer-type dementia and vascular dementia.
    Inagaki T; Shikimi T; Ishino H; Okunishi H; Takaori S
    Psychiatry Clin Neurosci; 1995 Dec; 49(5-6):287-90. PubMed ID: 8726115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nullification of a positive correlation between urinary levels of alpha 1-microglobulin and ulinastatin by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
    Shikimi T; Inagaki T; Kaku K; Ishino H; Okunishi H; Takaori S
    Psychoneuroendocrinology; 1997 May; 22(4):269-75. PubMed ID: 9226730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex- and age-related changes in urinary contents of alpha 1-microglobulin and ulinastatin in mice.
    Shikimi T; Suzuki S; Kaku K; Ishino H; Okunishi H; Takaori S
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):614-7. PubMed ID: 10474775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the correlation between urinary contents of alpha-1-microglobulin and ulinastatin is induced by intracerebroventricularly administered interleukin-6 in mice.
    Kaku K; Shikimi T; Inagaki T; Ishino H; Okunishi H; Takaori S
    Neuropsychobiology; 1999; 40(1):33-9. PubMed ID: 10420099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant decreases of ulinastatin-like immunoreactive substance in the cerebrospinal fluid of patients with dementia.
    Shikimi T; Inagaki T; Ishino H; Kobayashi S; Matsubara K; Okunishi H; Takaori S
    Neuropsychobiology; 1997; 35(4):187-90. PubMed ID: 9246219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum contents of the free forms of alpha(1)-microglobulin and ulinastatin: relation to diseased states in patients with mood disorders.
    Shikimi T; Kaku K; Uegaki J; Inagaki T; Seno H; Ishino H; Takaori S
    Neuropsychobiology; 2001; 43(3):145-9. PubMed ID: 11287793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the regression slope correlating between urinary contents of alpha-1-microglobulin and ulinastatin and its relation to severity in mood disorders.
    Shikimi T; Uegaki J; Inagaki T; Mitsuoka S
    Nurs Health Sci; 2001 Jun; 3(2):95-100. PubMed ID: 11882184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nullification of a positive correlation between urinary contents of alpha1-microglobulin and ulinastatin with intracerebroventricularly administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) in mice.
    Kaku K; Shikimi T; Kamisaki Y; Inagaki T; Ishino H; Okunishi H; Takaori S
    Psychopharmacology (Berl); 1998 Apr; 136(4):374-8. PubMed ID: 9600583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in the equilibrium of the levels of free and bound forms of alpha1-microglobulin and ulinastatin in patients with mood disorders.
    Uegaki J; Shikimi T; Kaku K; Takaori S
    Neuropsychobiology; 2002; 45(2):62-6. PubMed ID: 11893861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy.
    Matsumoto K; Shichijo F; Fukami T
    J Neurosurg; 1984 May; 60(5):1033-44. PubMed ID: 6716138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
    Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
    Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha 1-microglobulin and its relationship to renal function.
    Kusano E; Suzuki M; Asano Y; Itoh Y; Takagi K; Kawai T
    Nephron; 1985; 41(4):320-4. PubMed ID: 2415841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the ratio of urinary alpha 1-microglobulin to ulinastatin levels in patients with psychiatric diseases.
    Inagaki T; Shikimi T; Fujimoto A; Ishino H; Okunishi H; Takaori S
    Biol Psychiatry; 1996 Oct; 40(8):800-3. PubMed ID: 8894075
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between ulinastatin and alpha-1-microglobulin in human urine.
    Shikimi T; Himeno Y; Shigeno K; Gonda T; Ishibe T; Hattori K; Takaori S
    Clin Chim Acta; 1994 Jun; 227(1-2):195-200. PubMed ID: 7525118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Motor evoked potentials of transcranial magnetic stimulation for Parkinson's disease].
    Shimamoto H; Morimitsu H; Sugita S; Kimihiro N; Shigemori M; Kurihara Y
    No To Shinkei; 1996 Sep; 48(9):825-9. PubMed ID: 8888031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract]   [Full Text] [Related]  

  • 19. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.